ER-60 (PDIA3) is highly expressed in a newly established serous ovarian cancer cell line, YDOV-139

Medicine and Dentistry

• Ovarian Cancer 100%
• Neoplasm 40%
• Biological Marker 40%
• Real Time Polymerase Chain Reaction 40%
• Immunohistochemistry 40%
• Chemosensitivity 40%
• Ovarian Cancer Cell Line 40%
• Messenger RNA 20%
• Protein 20%
• Morphology 20%
• Peptide Mass Fingerprinting 20%
• Biological Product 20%
• Proteomics 20%
• Gene Expression 20%
• Epithelial Cell 20%
• cDNA Microarray 20%
• Gemcitabine 20%
• Cell Lineage 20%
• Two Dimensional Gel Electrophoresis 20%
• Ascites 20%
• Cancer Research 20%
• Recurrent Ovarian Cancer 20%
• HLA Typing 20%

Biochemistry, Genetics and Molecular Biology

• PDIA3 100%
• Cancer Cell 40%
• Real-Time Polymerase Chain Reaction 40%
• Chemosensitivity 40%
• Morphology 20%
• Nested Gene 20%
• Proteomics 20%
• Peptide Mass Fingerprinting 20%
• Gene Expression 20%
• Matrix-Assisted Laser Desorption/Ionization 20%
• Nude Mouse 20%
• Allele 20%
• Two-Dimensional Gel Electrophoresis 20%
• Gemcitabine 20%
• LCN2 20%
• HLA Typing 20%

Agricultural and Biological Sciences

• Cell Lines 60%
• Real-Time Polymerase Chain Reaction 40%
• Biomarkers 40%
• Immunohistochemistry 40%
• Proteins 20%
• Gene Expression 20%
• Matrix-Assisted Laser Desorption/Ionization 20%
• Proteomics 20%
• Peptide Mass Fingerprinting 20%
• Epithelial Cells 20%
• Two-Dimensional Gel Electrophoresis 20%
• LCN2 20%